I define market-leading product strategies and translate them into high-velocity delivery roadmaps that drive top-line expansion and bottom-line efficiency across the provider, payer, and pharma ecosystems. With 20+ years of executive leadership, I specialize in transforming complex commercial visions into AI-native platforms and the high-performing product organizations required to sustain them at scale.
Stealth & R&D
Building a stealth-state platform designed to solve systemic data liquidity challenges and unlock enterprise value across the health ecosystem. I am architecting the AI-native infrastructure required to bridge fragmented market gaps, empowering the individual with meaningful access to their health data story while enabling scalable, cross-sector commercial growth.
2024 — 2026
Defined and delivered a 0-1 product strategy. Translated enterprise vision into engineering-ready roadmaps, secured two national health plan investors, and managed a $20M operating budget to build a 35-person product organization from scratch.
2022 — 2023
Spearheaded the product-led transformation for a PE-backed Real-World Data company. Redefined the commercial roadmap to align with pharma R&D needs, facilitating a successful acquisition by Zephyr AI.
2019 — 2022
Owned P&L for a $150M multi-product portfolio. Scaled the product team from 8 to 25, achieved 2x revenue growth, and drove significant bottom-line efficiency by aligning global product roadmaps with enterprise commercial cycles.